You have probably heard the talk by now. Microdosing LSD has moved from Silicon Valley rumor into everyday wellness chatter, promising sharper focus for anyone willing to try. The idea is that the same small drop should do the same thing for everyone.
New research presented at the 39th ECNP Congress in Munich suggests the picture is more complicated. In a pilot trial from the University of Maastricht, low doses of LSD sharpened women's sustained attention.
Men who took the same dose got no measurable improvement, according to the European College of Neuropsychopharmacology, which hosted the meeting from October 10 to 13, 2026.
What the Maastricht team actually measured
The randomized, double-blind, placebo-controlled study followed 48 healthy adults, half of them women, with an average age of 36.9 years. Over two weeks, participants received either placebo or four microdoses of 15 micrograms of LSD.
Also read: Childhood cancer symptoms are most often mistaken for everyday illness
Researchers assessed three cognitive areas, sustained attention, information processing and working memory. The clearest result sat in sustained attention.
Women on microdoses responded about 8 percent faster to visual signals than when they took placebo. Their lapses in attention, the moments the brain simply misses a cue, were cut roughly in half. Men saw no comparable change.
Women on placebo started off slower and lapsed more often than men on placebo. The microdose appeared to close that gap rather than push women past men.
The improvements in women showed up after the very first dose, held through repeated dosing, and were still visible at follow-up testing.
Also read: Feeling physically weaker or slower than before? Your heart may be sending a warning years early
Why biological sex may matter in psychedelic research
Lead researcher Iva Totomanova, from the University of Maastricht, cautioned against reading too much into one small trial.
"This is a small pilot study, so it does need to be confirmed in a larger population," she said. She also stressed the findings do not show that LSD generally improves thinking, or that women are universally more responsive to the drug.
The sex-split result still matters because most microdosing research has treated men and women as interchangeable subjects. A 2026 review in Frontiers in Psychiatry pulled together animal evidence showing sex-based differences in how psychedelics act on the brain.
That review found that estrogen raises the density of the 5-HT2A serotonin receptors psychedelics target. The same dose may land differently in a woman's brain than in a man's.
Also read: More than half of young adults put their type 2 diabetes into remission without drugs
What this means if you are already microdosing
Microdosing has shifted from a fringe practice to a mainstream wellness topic, with users typically chasing better focus, mood or creativity. The new data suggest some may be getting less than they bargained for, and others more.
LSD remains a Schedule I substance under US federal law. Anyone weighing a change in medication or supplement for attention problems should talk with a doctor first.
Totomanova's team now plans studies designed to pin down the sex difference, tracking hormone concentrations, menstrual phase and contraceptive use.
Also read: An AI learned to see a migraine coming the next day, from a signal clinicians often overlook
Also read: The same workout may affect men’s and women’s livers differently
This article is made and published by Aksel Kryhlmand, who may have used AI in the preparation.